Detalhe da pesquisa
1.
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer.
Int J Cancer
; 154(9): 1607-1615, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196128
2.
Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan.
Cancer Sci
; 115(2): 507-528, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047872
3.
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Jpn J Clin Oncol
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594880
4.
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Lancet
; 397(10272): 375-386, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485464
5.
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
Jpn J Clin Oncol
; 51(8): 1269-1276, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115855
6.
Physician requests by patients with malignant pleural mesothelioma in Japan.
BMC Cancer
; 19(1): 383, 2019 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31023248
7.
Serum levels of the chemokine CCL2 are elevated in malignant pleural mesothelioma patients.
BMC Cancer
; 19(1): 1204, 2019 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823764
8.
Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study.
BMC Cancer
; 18(1): 350, 2018 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29587685
9.
[Clinical Pathological Diagnosis, and Treatment for Pleural Mesothelioma].
Gan To Kagaku Ryoho
; 43(5): 513-7, 2016 May.
Artigo
em Japonês
| MEDLINE | ID: mdl-27210080
10.
Pilot Analysis of Asbestos-induced Diffuse Pleural Thickening with Respiratory Compromise.
Acta Med Okayama
; 69(5): 261-6, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26490022
11.
Asbestos-related diffuse pleural thickening.
Respiration
; 88(4): 277-84, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25171783
12.
Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.
J Cancer Res Clin Oncol
; 150(2): 89, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347279
13.
Treatment and survival analyses of malignant mesothelioma in Japan.
Acta Oncol
; 52(4): 803-8, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22928694
14.
Severe cardiotoxicity induced by osimertinib in a patient with EGFR-mutated adenocarcinoma of the lung.
BMJ Case Rep
; 16(7)2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37479487
15.
Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201.
PLoS One
; 18(5): e0285273, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205678
16.
Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma.
Carcinogenesis
; 33(7): 1277-85, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22532250
17.
National survey of malignant mesothelioma and asbestos exposure in Japan.
Cancer Sci
; 103(3): 483-90, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22126592
18.
Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma.
Cancer Sci
; 103(3): 510-4, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22146010
19.
The Rapid Appearance and Disappearance of Dendriform Pulmonary Ossification after Diffuse Alveolar Hemorrhage.
Am J Respir Crit Care Med
; 193(3): 333-4, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407122
20.
Thrombocytopenia as an Immune-Related Adverse Event in Malignant Pleural Mesothelioma: A Case Report.
JTO Clin Res Rep
; 3(7): 100351, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35795882